[
  {
    "ts": null,
    "headline": "Bio-Techne Announces Exosome Diagnostics Divestiture",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets. Bio-Techne will retain access to the proprietary exosome-based technology for ongoing kit development in its precision diagnostics growth pillar.",
    "url": "https://finnhub.io/api/news?id=38497a45ac53aa48d2eeee3aacce1bcba7b30d7bbb1684747a60e80c90df78c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754425800,
      "headline": "Bio-Techne Announces Exosome Diagnostics Divestiture",
      "id": 136217402,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets. Bio-Techne will retain access to the proprietary exosome-based technology for ongoing kit development in its precision diagnostics growth pillar.",
      "url": "https://finnhub.io/api/news?id=38497a45ac53aa48d2eeee3aacce1bcba7b30d7bbb1684747a60e80c90df78c0"
    }
  },
  {
    "ts": null,
    "headline": "ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine",
    "summary": "ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sidra Medicine, a women and children's hospital in Qatar, has been awarded a $100,000 G-Rex® Grant. Sidra Medicine's G-Rex® Grant will enable expeditious development, validation, and implementation of a G-Rex® centric CAR-T cell production platform.",
    "url": "https://finnhub.io/api/news?id=4be944113fe6f9de2f2c5370b4bc220dbbc211f62fcdecbc366645732fe51e78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754391600,
      "headline": "ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine",
      "id": 136212880,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sidra Medicine, a women and children's hospital in Qatar, has been awarded a $100,000 G-Rex® Grant. Sidra Medicine's G-Rex® Grant will enable expeditious development, validation, and implementation of a G-Rex® centric CAR-T cell production platform.",
      "url": "https://finnhub.io/api/news?id=4be944113fe6f9de2f2c5370b4bc220dbbc211f62fcdecbc366645732fe51e78"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne: Coveted Life Sciences Asset On Sale Due To Academic Pressures",
    "summary": "Headwaters Capital sees deep value in Bio-Techne as academic cuts weigh on shares. Learn why this life sciences leader could rebound in 2027âread the thesis.",
    "url": "https://finnhub.io/api/news?id=c0f8643ff6a9b2b5a2471056042b67ba3b521f1def3d5eb2f936fdb1bee4ce1a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754390700,
      "headline": "Bio-Techne: Coveted Life Sciences Asset On Sale Due To Academic Pressures",
      "id": 136213726,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1168939901/image_1168939901.jpg?io=getty-c-w1536",
      "related": "TECH",
      "source": "SeekingAlpha",
      "summary": "Headwaters Capital sees deep value in Bio-Techne as academic cuts weigh on shares. Learn why this life sciences leader could rebound in 2027âread the thesis.",
      "url": "https://finnhub.io/api/news?id=c0f8643ff6a9b2b5a2471056042b67ba3b521f1def3d5eb2f936fdb1bee4ce1a"
    }
  },
  {
    "ts": null,
    "headline": "Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow",
    "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) will be reporting results this Wednesday before market open. Here’s what investors should know.",
    "url": "https://finnhub.io/api/news?id=e9cbe1a2dc5b0ed201dac8cdd2a1940568dc9f258ca6df99e976df74d9f7d89c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754363991,
      "headline": "Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow",
      "id": 136206245,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) will be reporting results this Wednesday before market open. Here’s what investors should know.",
      "url": "https://finnhub.io/api/news?id=e9cbe1a2dc5b0ed201dac8cdd2a1940568dc9f258ca6df99e976df74d9f7d89c"
    }
  }
]